Functional Polymorphism of the Thymidylate Synthase Gene in Colorectal Cancer Accompanied by Frequent Loss of Heterozygosity
Open Access
- 1 November 2002
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 93 (11) , 1221-1229
- https://doi.org/10.1111/j.1349-7006.2002.tb01227.x
Abstract
The thymidylate synthase (TS) gene has a polymorphic repeated sequence in its 5′‐untranslated region. The repeat length is associated with TS protein expression, which suggests that we may be able to predict the efficacy of 5‐fluorouracil (S‐FU)‐based chemotherapy from a patient's TS genotype determined through analysis of normal tissue obtained non‐invasively. However, it is not yet elucidated whether the TS genotype is identical in tumor and normal tissue. In this study, we investigated the TS genotype in 151 matched tumor and normal DNA samples isolated from colorectal cancer and adjacent normal tissues by PCR analysis. The results showed that TS genotypes are identical in normal and tumor tissues of homozygous individuals, suggesting that the repeat sequence is stable through carcinogenesis. However, in heterozygous samples, an unbalance between the 2R and 3R alleles in the tumor DNA was frequently observed, suggesting loss of heterozygosity (LOH) at the TS locus. Detailed LOH analysis revealed that 62% (31 of 50) of 2R/3R‐heterozygous samples had LOH. Frequent LOH at the TS locus was confirmed by RT‐PCR of TS mRNA and microsatellite analysis using the marker D18S59, located on 18p11.3. There was no difference in the expressions of TS mRNA and TS protein between LOH and non‐LOH samples. However, when the heterozygous genotype bearing LOH was subdivided according to the number of repeats, the cancer tissue with 2R/loss genotype expressed a significantly lower level of TS protein than did that with 3R/loss genotype. The results suggest that the difference in TS genotype between tumor and normal tissue due to LOH should be considered when the genotype is analyzed with normal tissue, such as peripheral blood cells, because it is important for TS protein expression.Keywords
This publication has 23 references indexed in Scilit:
- Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.2001
- A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracilBritish Journal of Cancer, 2001
- Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancerInternational Journal of Oncology, 2001
- Polymorphisms of the Repeated Sequences in the Enhancer Region of the Thymidylate Synthase Gene Promoter May Predict Downstaging After Preoperative Chemoradiation in Rectal CancerJournal of Clinical Oncology, 2001
- Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapyThe Pharmacogenomics Journal, 2001
- Characterization of Nuclear Factors that Bind to the Human Thymidylate Synthase Gene in HL-60 Cells Differentiated by All-trans Retinoic Acid Treatnent.Biological & Pharmaceutical Bulletin, 2001
- Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy.International Journal of Oncology, 2000
- Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breastOncogene, 1998
- Functional Analysis and DNA Polymorphism of the Tandemly Repeated Sequences in the 5'-terminal Regulatory Region of the Human Gene for Thymidylate Synthase.Cell Structure and Function, 1995
- Thymidylate synthetase - a target enzyme in cancer chemotherapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1977